1250mg Niclosamide Bolus for Cattle
Composition
Each bolus contains:
Niclosamide: 1250mg.
Pharmacology and Toxicology
This product can inhibit the oxidative phosphorylation process of mitochondria in the tapeworm cells. At high concentrations, it can inhibit the respiration of the worm body and block the uptake of glucose, thereby causing it to deteriorate. The drug can destroy the head and anterior segment of the body segment, and part of it is digested and difficult to identify when it is discharged. This product has no killing effect on eggs.
Indications
Niclosamide bolus is used for animal tapeworm infections. It is a good medicine for the treatment of Taenia saginata, Hymenoderma brevisiae, Schizocephala latifolia and other infections. It is also effective against Taenia solium, but it may increase the possibility of infection with cysticercosis after taking the medicine.
Sheep and goats:
Moniezia spp., Stilesia spp., Avitellina spp. and immature intestinal Paramphistomiasis spp. in the pathogenic juvenile stage.(intestinal stage)
Dogs and Cats: Taenia spp., Dipylidium caninum, Echinococcus granulosus (tentatively).
Dosage & Administration
By oral administration:
Sheep and Goats : 75 – 80 mg of Niclosamide per kg Bodyweight or one bolus for 15 kg Bodyweight.
Cattle : 60 – 65 mg of Niclosamide per kg Bodyweight or one bolus for 20 kg Bodyweight
Dogs : 125 mg of Niclosamide per kg Bodyweight or one bolus for 10 kg Bodyweight
Cats : 125 mg of Niclosamide per kg Bodyweight or 1/3 bolus for 3.3 kg Bodyweight
Precautions
Sheep and goats can be turned out to wasteland which will not be used for grazing in the next weeks following the treatment, and which is exposed to intensive sunlight of the infested sheep, the lambs and the yearlings should in the first place be treated. In cattle, it is generally necessary to treat only the young animals up to 6-8 months old, as the older will develop immunity after this time. Niclosam can be used in pregnant animals. Niclosam should not be used in the presence of intestinal Atonia in order to avoid the risk of absorption of decomposition of the killed tapeworms.
Withdrawal Times
Sheep : 28days.
Cattle : 28days.
Storage
Store in a cool place. Protect from light
Keep out of reach of children.
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 11 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own- label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific management. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.